Optical Frequency Domain Imaging for Assessing Colonic Polyps

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01439087
Collaborator
(none)
2
1
1
13
0.2

Study Details

Study Description

Brief Summary

The goal of this research is to conduct a pilot clinical study to image colonic polyps with the intent to evaluate the potential use of Optical Frequency Domain Imaging (OFDI) to identify the extent of invasion (if present), differentiate between hyperplastic polyps and adenomas, and identify serrated polyps.

Condition or Disease Intervention/Treatment Phase
  • Device: MGH Optical Frequency Domain Imaging (OFDI) System
N/A

Detailed Description

The colon OFDI catheter will be used in conjunction with a sigmoidoscope. If a sigmoid polyp is identified, the colonoscope will be removed and a sigmoidoscope inserted. The colon OFDI catheter will be advanced through the sigmoidoscope accessory port and positioned adjacent to the colon wall. Imaging will be performed with the OFDI system across the polyp's surface and the base/stalk if pedunculated. The investigators anticipate that on average the investigators will utilize 4 helical scans per polyp. Each of the scans will take less than 30 seconds.

Study Design

Study Type:
Interventional
Actual Enrollment :
2 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Pilot Study to Evaluate Optical Frequency Domain Imaging as a Tool for Assessing Colonic Polyps
Actual Study Start Date :
Jul 1, 2009
Actual Primary Completion Date :
Oct 1, 2009
Actual Study Completion Date :
Aug 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: OFDI imaging

OFDI imaging

Device: MGH Optical Frequency Domain Imaging (OFDI) System
Imaging of Colonic Polyps with OFDI system

Outcome Measures

Primary Outcome Measures

  1. Feasibility and Sensitivity of OFDI Imaging in the Colon [During the OFDI imaging session which should take an average of 5 mintues]

    OFDI Images are analyzed and compared to standard of care biopsies in order to differentiate hyperplastic polyps from adenomas or to identify serrated polyps. A total of 15 subjects were consented, but upon inspection of the colon only 2 participants met the eligibility criteria and participated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing a screening colonoscopy

  • Patients must be over the age of 18

  • Patient must be able to give informed consent

Exclusion Criteria:
  • Patients with hemostasis disorders

  • Patients taking any anti-coagulants such as Coumadin or Plavix,

Contacts and Locations

Locations

Site City State Country Postal Code
1 Massachusetts General Hospital Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Guillermo Tearney, MD PhD, Massachusetts General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guillermo Tearney, Professor of Pathology, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01439087
Other Study ID Numbers:
  • 2009-P000946
First Posted:
Sep 22, 2011
Last Update Posted:
Dec 30, 2019
Last Verified:
Dec 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guillermo Tearney, Professor of Pathology, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title OFDI Imaging
Arm/Group Description OFDI imaging MGH Optical Frequency Domain Imaging (OFDI) System: Imaging of Colonic Polyps with OFDI system
Period Title: Overall Study
STARTED 2
COMPLETED 2
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title OFDI Imaging
Arm/Group Description OFDI imaging MGH Optical Frequency Domain Imaging (OFDI) System: Imaging of Colonic Polyps with OFDI system
Overall Participants 2
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
2
100%
>=65 years
0
0%
Sex: Female, Male (Count of Participants)
Female
1
50%
Male
1
50%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
0
0%
Not Hispanic or Latino
2
100%
Unknown or Not Reported
0
0%
Region of Enrollment (Count of Participants)
United States
2
100%

Outcome Measures

1. Primary Outcome
Title Feasibility and Sensitivity of OFDI Imaging in the Colon
Description OFDI Images are analyzed and compared to standard of care biopsies in order to differentiate hyperplastic polyps from adenomas or to identify serrated polyps. A total of 15 subjects were consented, but upon inspection of the colon only 2 participants met the eligibility criteria and participated.
Time Frame During the OFDI imaging session which should take an average of 5 mintues

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Feasibility & Sensitivity of OFDI Imaging in the Colon
Arm/Group Description Feasibility is measured by the number of enrolled subjects that met imaging eligibility criteria and were successfully imaged with the OFDI device. Sensitivity is measured by the number of enrolled subjects that met eligibility criteria, and had a polyp(s) successfully imaged and identified by the OFDI device.
Measure Participants 2
Feasibility
2
100%
Sensitivity
1
50%

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title OFDI Imaging
Arm/Group Description OFDI imaging MGH Optical Frequency Domain Imaging (OFDI) System: Imaging of Colonic Polyps with OFDI system
All Cause Mortality
OFDI Imaging
Affected / at Risk (%) # Events
Total 0/2 (0%)
Serious Adverse Events
OFDI Imaging
Affected / at Risk (%) # Events
Total 0/2 (0%)
Other (Not Including Serious) Adverse Events
OFDI Imaging
Affected / at Risk (%) # Events
Total 0/2 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Gary Tearney, MD, PhD
Organization Massachusetts General Hospital
Phone 617-724-2979
Email GTEARNEY@PARTNERS.ORG
Responsible Party:
Guillermo Tearney, Professor of Pathology, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01439087
Other Study ID Numbers:
  • 2009-P000946
First Posted:
Sep 22, 2011
Last Update Posted:
Dec 30, 2019
Last Verified:
Dec 1, 2019